Moleculin Biotech: files Regulation FD disclosure and investor presentation

What happened Moleculin Biotech filed a Form 8-K on Oct 5, 2026, reporting a Regulation FD disclosure and stating that it is using the attached presentation for its corporate presentation posted on the company’s website. The presentation is set forth as Exhibit 99.1 in the filing.

Key details

• Item reported: 7.01 Regulation FD disclosure; the company says it is using the attached presentation for its corporate presentation.
• Exhibits filed under Item 9.01 include Exhibit 99.1, an investor presentation dated Oct 5, 2026, and a Cover page Interactive Data File (Inline XBRL) as Exhibit 104.
• The filing was submitted on Oct 5, 2026.

Why it may matter Item 7.01 covers Regulation FD disclosure, which in this filing consists of an investor presentation the company is posting on its website and including as an exhibit. Item 9.01 lists the exhibits furnished with the Form 8-K. This filing does not show why the insider traded or why the company acted.